Gary B. Freeman

1.0k total citations
25 papers, 833 citations indexed

About

Gary B. Freeman is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Gary B. Freeman has authored 25 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Gary B. Freeman's work include Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Alzheimer's disease research and treatments (3 papers). Gary B. Freeman is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Alzheimer's disease research and treatments (3 papers). Gary B. Freeman collaborates with scholars based in United States. Gary B. Freeman's co-authors include Gary E. Gibson, Rosalind A. Schoof, Andy Davis, Paul D. Bergstrom, Michael V. Ruby, Timothy E. Link, Rufus L. Chaney, Mark Bloom, John P. Blass and Hsueh‐Meei Huang and has published in prestigious journals such as Environmental Science & Technology, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Gary B. Freeman

25 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary B. Freeman United States 15 302 218 196 139 133 25 833
Andrew D. Monnot United States 20 163 0.5× 459 2.1× 74 0.4× 183 1.3× 59 0.4× 55 1.4k
Eija Schultz Finland 17 382 1.3× 245 1.1× 87 0.4× 139 1.0× 50 0.4× 31 1.0k
Robert A. Howd United States 21 154 0.5× 477 2.2× 120 0.6× 132 0.9× 33 0.2× 44 1.3k
Marisela Méndez‐Armenta Mexico 19 431 1.4× 948 4.3× 253 1.3× 286 2.1× 27 0.2× 53 1.9k
Verónica M. Rodríguez Mexico 20 202 0.7× 711 3.3× 176 0.9× 336 2.4× 490 3.7× 36 1.5k
Michael Aschner United States 20 108 0.4× 813 3.7× 196 1.0× 225 1.6× 22 0.2× 45 1.5k
A. Santagostino Italy 18 213 0.7× 290 1.3× 299 1.5× 318 2.3× 28 0.2× 49 1.4k
Zhaoxiang Zhou China 13 118 0.4× 257 1.2× 95 0.5× 86 0.6× 18 0.1× 29 730

Countries citing papers authored by Gary B. Freeman

Since Specialization
Citations

This map shows the geographic impact of Gary B. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary B. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary B. Freeman more than expected).

Fields of papers citing papers by Gary B. Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary B. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary B. Freeman. The network helps show where Gary B. Freeman may publish in the future.

Co-authorship network of co-authors of Gary B. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Gary B. Freeman. A scholar is included among the top collaborators of Gary B. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary B. Freeman. Gary B. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freeman, Gary B., Thomas Brown, Karin Wallace, & Kelly R. Bales. (2012). Chronic Administration of an Aglycosylated Murine Antibody of Ponezumab Does Not Worsen Microhemorrhages in Aged Tg2576 Mice. Current Alzheimer Research. 9(9). 1059–1068. 15 indexed citations
2.
Freeman, Gary B., et al.. (2012). 39-Week Toxicity and Toxicokinetic Study of Ponezumab (PF-04360365) in Cynomolgus Monkeys with 12-Week Recovery Period. Journal of Alzheimer s Disease. 28(3). 531–541. 24 indexed citations
3.
Goodman, James, et al.. (2012). P1‐136: Spontaneous ARIA‐E and ARIA‐H in Aged APP+PS1 Mice. Alzheimer s & Dementia. 8(4S_Part_4). 1 indexed citations
4.
5.
Davis, Andy, Michael V. Ruby, Mark Bloom, et al.. (1996). Mineralogic Constraints on the Bioavailability of Arsenic in Smelter-Impacted Soils. Environmental Science & Technology. 30(2). 392–399. 98 indexed citations
6.
Gibson, Gary E., John P. Blass, Hsueh‐Meei Huang, & Gary B. Freeman. (1991). The Cellular Basis of Delirium and Its Relevance to Age-Related Disorders Including Alzheimer’s Disease. International Psychogeriatrics. 3(2). 373–395. 46 indexed citations
7.
Thurmond, John B., Gary B. Freeman, Joseph S. Soblosky, John R. Ieni, & John W. Brown. (1990). Effects of dietary tyrosine on L-dopa- and amphetamine-induced changes in locomotor activity and neurochemistry in mice. Pharmacology Biochemistry and Behavior. 37(2). 259–266. 4 indexed citations
8.
Gibson, Gary E., et al.. (1989). Cytosolic-free calcium and neurotransmitter release with decreased availability of glucose or oxygen. Neurochemical Research. 14(5). 437–443. 42 indexed citations
9.
Freeman, Gary B. & Gary E. Gibson. (1988). Dopamine, Acetylcholine, and Glutamate Interactions in Aging Behavioral and Neurochemical Correlates. Annals of the New York Academy of Sciences. 515(1). 191–202. 30 indexed citations
10.
Gibson, Gary E., et al.. (1988). Selective damage in striatum and hippocampus with in vitro anoxia. Neurochemical Research. 13(4). 329–335. 9 indexed citations
11.
Freeman, Gary B., et al.. (1987). Effect of age on behavioral and enzymatic changes during thiamin deficiency. Neurobiology of Aging. 8(5). 429–434. 19 indexed citations
12.
Freeman, Gary B., et al.. (1987). Differential alteration of dopamine, acetylcholine, and glutamate release during anoxia and/or 3,4-diaminopyridine treatment. Neurochemical Research. 12(11). 1019–1027. 37 indexed citations
13.
Freeman, Gary B. & John B. Thurmond. (1986). Monoamines and effects of chlordiazepoxide on the corticosterone response to stress. Physiology & Behavior. 37(6). 933–938. 14 indexed citations
14.
Freeman, Gary B., et al.. (1986). Monoamine Neurotransmitter Metabolism and Locomotor Activity During Chemical Hypoxia. Journal of Neurochemistry. 46(3). 733–738. 24 indexed citations
15.
Freeman, Gary B., et al.. (1986). Behavioral and neurochemical correlates of morphine and hypoxia interactions. Pharmacology Biochemistry and Behavior. 24(6). 1687–1693. 4 indexed citations
16.
Freeman, Gary B., et al.. (1986). Automated method to estimate catecholamine and indoleamine content and turnover rates. Journal of Chromatography B Biomedical Sciences and Applications. 374(2). 239–249. 6 indexed citations
17.
Freeman, Gary B. & Gary E. Gibson. (1986). Effect of Decreased Oxygen on In Vitro Release of Endogenous 3,4‐Dihydroxyphenylethylamine from Mouse Striatum. Journal of Neurochemistry. 47(6). 1924–1931. 20 indexed citations
18.
Freeman, Gary B. & John B. Thurmond. (1985). Brain amines and effects of chlordiazepoxide on motor activity in response to stress. Pharmacology Biochemistry and Behavior. 22(5). 665–670. 8 indexed citations
19.
Freeman, Gary B., et al.. (1981). Amrinone metabolism. Clinical Pharmacology & Therapeutics. 29(3). 394–401. 37 indexed citations
20.
Freeman, Gary B., et al.. (1978). Activity Analysis of Operant Behavior following Methylphenidate Administration. Perceptual and Motor Skills. 47(1). 163–167. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew D. Monnot Breakdown of academic impact, for papers by Eija Schultz Breakdown of academic impact, for papers by Robert A. Howd Breakdown of academic impact, for papers by Marisela Méndez‐Armenta Breakdown of academic impact, for papers by Verónica M. Rodríguez Breakdown of academic impact, for papers by Michael Aschner Breakdown of academic impact, for papers by A. Santagostino Breakdown of academic impact, for papers by Zhaoxiang Zhou
Rankless by CCL
2026